Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:007370)

South Korea · Delayed Price · Currency is KRW

4,030.00

+85.00 (2.15%)

At close: Aug 24, 2026

-30.03% (1Y)

Market Cap	50.93B -26.5%
Revenue (ttm)	124.61B +4.1%
Net Income	22.80B -20.7%
EPS	n/a
Shares Out	12.91M
PE Ratio	2.23
Forward PE	n/a
Dividend	150.00 (3.80%)
Ex-Dividend Date	Dec 29, 2025

Volume	21,847
Open	3,945.00
Previous Close	3,945.00
Day's Range	3,945.00 - 4,050.00
52-Week Range	3,350.00 - 6,040.00
Beta	0.33
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Jin Yang Pharmaceutical

Jin Yang Pharmaceutical Co., Ltd. engages in the pharmaceutical business in South Korea. The company offers crivix tablets, Eszol tablets, atolan tablets, prescription drugs, and over-the-counter drugs. It also offers antilipidemic, antiplatelet, gastrointestinal, and respiratory agents; antithrombotics; NSAIDs; menopause symptoms treatment; and stomatological products. The company also exports its products. Jin Yang Pharmaceutical Co., Ltd. was founded in 1971 and is headquartered in Seoul, South Korea. [Read more]

Industry Pharmaceutical Preparations

Founded 1971

Employees 220

Stock Exchange KOSDAQ

Ticker Symbol 007370

Full Company Profile

Financial Performance

In 2025, Jin Yang Pharmaceutical's revenue was 120.69 billion, an increase of 6.49% compared to the previous year's 113.33 billion. Earnings were 22.29 billion, a decrease of -24.95%.

Financial Statements